Athelas
Athelas develops at-home diagnostic devices and clinical laboratory services to enable remote monitoring of patients, with a focus on point-of-care blood testing and digital health analytics. The company pairs compact capillary blood analyzers with cloud-based data and clinical workflows to deliver lab-grade results, support oncology and chronic disease management, and integrate results into care-team processes.
Leadership & Board
- Current Number of Employees
- 311
- Current LinkedIn Followers
- 29,990
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $59M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $59M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Company Momentum Positive
Athelas LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Employee Trend
Athelas had 311 employees as of October 12, 2026. The number of employees decreased by 2 (0.64%) week-over-week.
Social Trend
Athelas had 29,990 followers as of October 12, 2026. The number of followers increased by 158 (0.53%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 03, 2022 | Series C | $59.40M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Tribe Capital | Series C |
Similar Companies
A snapshot of private companies similar to Athelas, helping you discover and navigate related company profiles.
Related News and Analysis
